[EQ] Chronic Disease: An Economic Perspective

Chronic Disease: An Economic Perspective

 

Marc Suhrcke, WHO Regional Office for Europe (Venice, Italy)

Rachel A. Nugent, director of health and economics at the Population Reference Bureau.

David Stuckler, working with OxHA members and the WHO on issues pertaining to the global governance of chronic diseases.

Lorenzo Rocco, assistant professor of economics with the University of Padova in Italy.

London: Oxford Health Alliance

 

Web site: http://www.oxha.org/initiatives/economics/chronic-disease-an-economic-perspective

 

PDF [60p.]  at: http://www.oxha.org/initiatives/economics/knowledge/publications/oxha-chronic-disease-an-economic-perspective.pdf

“…..Chronic diseases account for the greatest share of early death and disability worldwide. Over the next few decades this burden is projected to rise particularly fast in the developing world. The lack of research on the economic implications of chronic disease contrasts with the available knowledge on the sheer epidemiological burden of the problem. This paper assesses and evaluates the current state of knowledge, with a primary focus on low- and middle-income countries, and a secondary focus on high-income countries (where information on the former is lacking). Very few such attempts have been undertaken, especially with an interest in developing countries. Thus a critical review of the available evidence is a necessary first step in exploring the case for governments and donors to invest in chronic disease prevention and in clarifying areas in which further research is required.

As the evidence is complex, the report should meet the needs of technical audiences for whom detailed knowledge is central as well as be accessible and useful to those for whom synthesised understandings are sufficient….”

Content

Executive summary

1 Introduction

2 The distribution of chronic disease by wealth and age

3 Economic consequences of chronic disease

4 The economic rationale for public-policy intervention against chronic disease

5 Cost-effectiveness of interventions to prevent chronic diseases

   5.1 What is cost-effectiveness?

   5.2 Barriers to measuring cost-effectiveness

   5.3 Gathering information about intervention cost-effectiveness

   5.4 Cost-effectiveness of interventions to prevent chronic diseases

   5.5 Conclusions

6 Further research needs and concluding remarks

 

 

*      *      *     * 
This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ KMC Area] 

“Materials provided in this electronic list are provided "as is".Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.
---------------------------------------------------------------------------------------------------

PAHO/WHO Website: http://66.101.212.219/equity/  

EQUITY List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html

 

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.